Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-08-23
2005-08-23
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S023000, C514S034000, C514S283000, C514S449000, C514S598000, C514S617000, C514S619000, C514S620000, C514S626000, C514S630000, C514S716000, C514S718000, C514S720000, C514S922000, C424S649000
Reexamination Certificate
active
06933320
ABSTRACT:
An antitumor combination comprising a stilbene derivative and an anticancer compound selected from the group consisting of taxanes, alkylating agents, antimetabolites, vinca alkaloids, platinum compounds, epidophylloptoxins, and antibiotics as the active ingredients is provided. Methods of using these pharmaceutical preparations for the treatment of solid carcinomas and the like are also provided.
REFERENCES:
patent: 4857653 (1989-08-01), Colin et al.
patent: 4996237 (1991-02-01), Pettit et al.
patent: 5430062 (1995-07-01), Cushman et al.
patent: 5525632 (1996-06-01), Obsumi et al.
patent: 5561122 (1996-10-01), Pettit
patent: 5674906 (1997-10-01), Hatanaka et al.
patent: 5731353 (1998-03-01), Ohsumi et al.
patent: 6462087 (2002-10-01), Morinaga et al.
patent: 6562834 (2003-05-01), Bissery
patent: 0 253 738 (1988-01-01), None
patent: 0 253 739 (1988-01-01), None
patent: WO 92/09589 (1992-06-01), None
patent: WO 02/056692 (2002-07-01), None
Corbett, T.H., et al., “Evaluation of Single Agents and Combinations of Chemotherapeutic Agents in Mouse Colon Carcinomas,”Cancer, 40(5), 1977, pp. 2660-2680.
Corbett, T.H., et al., “Response of Transplantable Tumors of Mice to Anthracenedione Derivatives Alone and in Combination With Clinically Useful Agents,”Cancer Treatment Reports, 66(5), 1982, pp. 1187-1200.
Schabel, Jr., F.M., et al., “Testing Therapeutic Hypotheses in Mice and Man: Observations on the Therapeutic Acitvity Against Advanced Solid Tumors of Mice Treated with Anticancer Drugs that have Demonstrated or Potential Clinical Utility for Treatment of Advanced Solid Tumors of Man,”Cancer Drug Development, Part B, Methods in Cancer Research, 17, 1979, pp. 3-51.
William J. Slichenmyer et al., The Current Status of Camptothecin Analogues as Antitumor Agents,J. Nat. Cancer Inst., 85:271-285 (1993).
Aventis Pharma S. A.
Balaram Gupta
Krass Frederick
LandOfFree
Combination comprising combretastatin and anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination comprising combretastatin and anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination comprising combretastatin and anticancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464493